Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5625697

NC1CCN(Cc2ccn3ncnc(Nc4cnc5ccccc5c4)c23)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 15/20 0.66
▸ ERBB2 P04626 15/20 0.66
▸ AAK1 Q2M2I8 5/20 0.60
▸ LCK P06239 2/20 0.57
▸ KDR P35968 2/20 0.57
▸ PRKD3 O94806 1/20 0.55
▸ PRKCG P05129 1/20 0.55
▸ PRKCB P05771 1/20 0.55
▸ CDK1 P06493 1/20 0.55
▸ MET P08581 1/20 0.55
▸ PRKCA P17252 1/20 0.55
▸ PRKCH P24723 1/20 0.55
▸ PRKCI P41743 1/20 0.55
▸ PRKCE Q02156 1/20 0.55
▸ PRKCQ Q04759 1/20 0.55
▸ PRKCZ Q05513 1/20 0.55
▸ PRKCD Q05655 1/20 0.55
▸ PRKD1 Q15139 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1219915 0.92 EGFR (0.74) EGFRERBB2AAK1LCKKDR
Trifluoroacetic Acid SCHEMBL5627012 0.90 EGFR (0.62) EGFRERBB2AAK1LCKKDR
Trifluoroacetic Acid SCHEMBL5629559 0.86 ERBB2 (0.63) EGFRERBB2AAK1LCKKDR
Trifluoroacetic Acid SCHEMBL5629155 0.84 EGFR (0.63) EGFRERBB2AAK1LCKKDR
Trifluoroacetic Acid SCHEMBL5625846 0.83 EGFR (0.84) EGFRERBB2AAK1LCKKDR
Trifluoroacetic Acid SCHEMBL5625586 0.83 EGFR (0.70) EGFRERBB2AAK1LCKKDR
SCHEMBL1220037 0.81 EGFR (0.70) EGFRERBB2AAK1LCKKDR
SCHEMBL1219548 0.81 EGFR (0.78) EGFRERBB2AAK1LCKKDR
Trifluoroacetic Acid SCHEMBL5626863 0.81 ERBB2 (0.61) EGFRERBB2AAK1LCKKDR
SCHEMBL1219490 0.81 ERBB2 (1.00) EGFRERBB2AAK1LCKKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7297695-B2 Pyrrolotriazine compounds as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-11-20 — — US disclosed
Send feedback